These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 18598201
21. Results of the multicentre evaluation of an electrochemiluminescence immunoassay for HCG on Elecsys 2010. Ehrhardt V, Assmann G, Bätz O, Bieglmayer C, Müller C, Neumeier D, Roth HJ, Veys A, Yvert JP. Wien Klin Wochenschr; 1998; 110 Suppl 3():61-7. PubMed ID: 9677673 [Abstract] [Full Text] [Related]
24. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma. Sedlaczek P, Frydecka I, Gabryś M, Van Dalen A, Einarsson R, Harłozińska A. Cancer; 2002 Nov 01; 95(9):1886-93. PubMed ID: 12404282 [Abstract] [Full Text] [Related]
26. Multicenter evaluation of the analytical and clinical performance of the Elecsys S100 immunoassay in patients with malignant melanoma. Alber B, Hein R, Garbe C, Caroli U, Luppa PB. Clin Chem Lab Med; 2005 Nov 01; 43(5):557-63. PubMed ID: 15899680 [Abstract] [Full Text] [Related]
29. [The value of CA125 and LDH assays in assisting diagnosis of epithelial ovarian carcinoma]. Qie M, Peng Z, Cao Z, Tang Q, He B. Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep 01; 27(3):310-3. PubMed ID: 9389070 [Abstract] [Full Text] [Related]
30. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses. Chen X, Zhou H, Chen R, He J, Wang Y, Huang L, Sun L, Duan C, Luo X, Yan H. Clin Chim Acta; 2015 Feb 02; 440():57-63. PubMed ID: 25447698 [Abstract] [Full Text] [Related]
31. A new tumour marker assay for ovarian cancer on the OPUS immunoassay system. Molz P, Teuter C, Schelp C, Amann E. Anticancer Res; 1997 Feb 02; 17(4B):3051-3. PubMed ID: 9329599 [Abstract] [Full Text] [Related]
36. Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward? Azzam AZ, Hashad DI, Kamel NA. Arch Gynecol Obstet; 2013 Jul 02; 288(1):167-72. PubMed ID: 23361457 [Abstract] [Full Text] [Related]
37. The role of CA125 in clinical practice. Moss EL, Hollingworth J, Reynolds TM. J Clin Pathol; 2005 Mar 02; 58(3):308-12. PubMed ID: 15735166 [Abstract] [Full Text] [Related]
38. Comparison of the Automated Fluorescent Immunoassay System With Roche Elecsys and Beckman Coulter Access 2 Assays for Anti-Müllerian Hormone Measurement. Han A, Suh B, Yi G, Lee YJ, Kim SE. Ann Lab Med; 2022 Jan 01; 42(1):47-53. PubMed ID: 34374348 [Abstract] [Full Text] [Related]
39. A sensitive and rapid immunoassay for quantification of CA125 in human sera by capillary electrophoresis with enhanced chemiluminescence detection. Wang J, Ren J. Electrophoresis; 2005 Jun 01; 26(12):2402-8. PubMed ID: 15895464 [Abstract] [Full Text] [Related]
40. Comparison of four 'second generation' immunoassay systems to determine CA 125 in serum by using a graphical approach to method comparison analysis. Koper NP, Thomas CM, Massuger LF, Segers MF, Kiemeney LA, Verbeek AL. Eur J Clin Chem Clin Biochem; 1997 Aug 01; 35(8):617-23. PubMed ID: 9298352 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]